Physician

Leslie Mccasland, M.D.

According to 2025 Medicare claims, Leslie Mccasland, M.D. (NPI: 1003873019) practices rheumatology in the Jonesboro, AR market, with the plurality of this provider's patient population coming from Craighead, AR. This provider's primary affiliated billing organization is ARTHRITIS AND RHEUMATISM ASSOCIATES LLC (NPI: 1396280780; TIN: 814595989) and primary practice location at 72401-6251. Mccasland is affiliated with the Baptist Connected Care Solutions, Inc. (ACO ID: A5693), participating under the MSSP model.

Mccasland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 632 traditional Medicare patients, billed 175,754 HCPCS/CPT codes, and received $1,845,679 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,969 prescription claims across 783 beneficiaries totaling $3,435,922 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 12 claims. Open Payments data shows 70 records totaling $66,109. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,958,520 to $3,435,922. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,230 and ending at $1,422.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	687	115,502	$1,278,495
2016	722	147,394	$1,653,733
2017	706	100,688	$1,536,970
2018	765	110,274	$2,010,291
2019	783	135,649	$2,438,755
2020	718	133,626	$2,230,473
2021	671	131,871	$1,989,486
2022	731	167,806	$2,032,411
2023	682	169,712	$2,167,661
2024	632	175,754	$1,845,679

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	624	10,315	$1,958,520
2016	655	11,158	$2,140,143
2017	669	10,655	$1,905,171
2018	719	10,855	$1,881,340
2019	754	10,525	$2,005,997
2020	720	10,214	$2,169,150
2021	743	10,668	$2,488,558
2022	751	9,623	$2,627,645
2023	753	8,570	$2,780,021
2024	783	8,969	$3,435,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$2,016
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	13	13	$941
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	55	$4,533
2023	N/R	12	$1,624
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	305	466	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	499	946	$52
80053	Blood test, comprehensive group of blood chemicals	381	958	$10
36415	Insertion of needle into vein for collection of blood sample	380	956	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	355	1,122	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	110	3,416	$920,994
Enbrel Sureclick	Etanercept	93	2,772	$768,633
Enbrel	Etanercept	39	1,108	$292,247
Humira(Cf)	Adalimumab	37	1,039	$270,506
Truxima	Rituximab-Abbs	18	296	$267,809

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$955	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$65,153	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Leslie Mccasland, M.D.?

Tedicare shows public-source Medicare data for Leslie Mccasland, M.D. (NPI 1003873019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Leslie Mccasland, M.D. have ACO affiliation data?

Leslie Mccasland, M.D. is shown with ACO affiliation data for Baptist Connected Care Solutions, Inc. (MSSP, ACO ID A5693).

What billing organization is linked to Leslie Mccasland, M.D.?

Leslie Mccasland, M.D. is linked to ARTHRITIS AND RHEUMATISM ASSOCIATES LLC (billing NPI 1396280780) in the available physician profile data.

Does Leslie Mccasland, M.D. have Open Payments data?

Leslie Mccasland, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.